Showing results (1201-1210 of 5,635) with videos related to
Sort By:
Pageof 564
BMC Neurology|October 23, 2023
Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot studyMax Kutzinski, Nicole Krause, Karin Riemann-Lorenz, et al.BMC Neurology|March 28, 2024
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of IrelandAshvin Kuri, David E Henshall, Daoud Chaudhry, et al.BMC Neurology|April 12, 2024
Red blood cell distribution width as a predictor of mortality and poor functional outcome after acute ischemic stroke: a meta-analysis and meta-regressionHuiqin Shen, Lihong ShenBMC Neurology|March 24, 2024
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]David Gibson, Anh Huan Vo, Hannah Lambing, et al.BMC Neurology|April 4, 2024
Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocolJonas E Svensson, Martin Bolin, Daniel Thor, et al.BMC Neurology|September 12, 2023
Prognostic value of contrast staining on dual-energy CT after endovascular therapy in acute ischemic stroke: a meta-analysisFan Yang, Yi Zeng, Fei Zhu, et al.BMC Neurology|September 15, 2023
Leptomeningeal neuraxis relapse in glioblastoma is an uncommon but not rare event associated with poor outcomeEric Wegener, Patrick Horsley, Helen Wheeler, et al.BMC Neurology|September 1, 2023
Peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells (CLPD-NK): a case report and literature reviewHong An, Jiaxiang Guo, Hongliang Guo, et al.BMC Neurology|August 30, 2023
Is coronary artery calcium an independent risk factor for white matter hyperintensity?Hui Jin, Xue Qin, Fanfan Zhao, et al.BMC Neurology|August 29, 2023
Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosisTakahiko Saida, Qi Hao, Michihiro Kanda, et al.Pageof 564